Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nomax is a privately held U.S. specialty pharmaceutical manufacturer focused on prescription and over-the-counter effervescent products, liquid formulations, medical devices, and selected dietary supplements. The company is best known for manufacturing effervescent potassium products such as Effer-K and for providing contract development and manufacturing services to other pharmaceutical companies. Nomax appears to operate primarily as a commercial-stage manufacturer rather than a clinical-stage drug developer, with capabilities spanning oral solid dosage, non-sterile liquids, packaging, and diagnostic strip products. Its business model combines its own niche branded or marketed products with fee-for-service manufacturing and formulation support for external customers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nomax.